Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Alpenglow, Anuncia, Asep, Coreplus, Jenavalve, Peijia Medical, Quansys Biosciences, Safecoat Medical, Signify Health, Sitero.
The U.S. Army needed 10 months to award a contract following a July 2022 request for proposals for flow cytometry and other clinical lab equipment, but Beckman Coulter Inc., filed an appeal that protested the award to Sysmex America Inc., of Lincolnshire, Ill. Beckman Coulter argued that Sysmex should have been disqualified from the bidding for failing to provide a technically acceptable proposal, but the Government Accountability Office decreed that the company’s protest failed because it was not filed within the required 10 days post-award.
In good news for those who toss and turn in the night with restless legs syndrome and their bed partners, bioelectronic technology appears to reduce the disruptive and uncontrolled movement. Researchers claimed that the NTX100 tonic motor activation (TOMAC) therapy, developed by Noctrix Health Inc., has the potential to transform treatment for people with restless legs syndrome (RLS) who are resistant to medications.
Rapidai Inc. landed $75 million in a series C financing led by Vista Credit Partners. The funds will be used to fuel development of additional indications and expand market reach of its artificial intelligence (AI)-powered clinical decisionmaking and workflow support technology. With this latest round, the San Mateo, Calif.-based company has raised approximately $100 million, according to Crunchbase.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Axial 3D, Imeka, Magnetiq-eye.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anteris Technologies, Augmedics, Electrocore, Fuzionaire, Holo Surgical, Juno, Pixium, Surgalign, T2, Tivic, Xtant.